739 related articles for article (PubMed ID: 19132232)
1. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
2. Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis.
Seitz I; Hess S; Schulz H; Eckl R; Busch G; Montens HP; Brandl R; Seidl S; Schömig A; Ott I
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):769-75. PubMed ID: 17255532
[TBL] [Abstract][Full Text] [Related]
3. PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells.
Zhang JJ; Kelm RJ; Biswas P; Kashgarian M; Madri JA
J Cell Physiol; 2007 Feb; 210(2):527-37. PubMed ID: 17111362
[TBL] [Abstract][Full Text] [Related]
4. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
5. CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway.
Chen Y; Wang J; Yao Y; Yuan W; Kong M; Lin Y; Geng D; Nie R
FEBS Lett; 2009 Sep; 583(17):2811-8. PubMed ID: 19631649
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
7. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells.
Zhao Y; Zhou S; Heng CK
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1645-50. PubMed ID: 17463335
[TBL] [Abstract][Full Text] [Related]
8. Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells.
Bobbert P; Antoniak S; Schultheiss HP; Rauch U
J Mol Cell Cardiol; 2008 Feb; 44(2):388-94. PubMed ID: 18054040
[TBL] [Abstract][Full Text] [Related]
9. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
[TBL] [Abstract][Full Text] [Related]
10. Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release.
Langer F; Morys-Wortmann C; Küsters B; Storck J
Br J Haematol; 1999 May; 105(2):542-50. PubMed ID: 10233435
[TBL] [Abstract][Full Text] [Related]
11. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
Petersen LC; Bjørn SE; Nordfang O
Thromb Haemost; 1992 May; 67(5):537-41. PubMed ID: 1519213
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of proteinase activated receptor-2 causes endothelial cells to promote blood coagulation in vitro.
Alm AK; Norström E; Sundelin J; Nystedt S
Thromb Haemost; 1999 Jun; 81(6):984-8. PubMed ID: 10404779
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases.
Dulon S; Candé C; Bunnett NW; Hollenberg MD; Chignard M; Pidard D
Am J Respir Cell Mol Biol; 2003 Mar; 28(3):339-46. PubMed ID: 12594060
[TBL] [Abstract][Full Text] [Related]
14. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
15. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis.
Adkison AM; Raptis SZ; Kelley DG; Pham CT
J Clin Invest; 2002 Feb; 109(3):363-71. PubMed ID: 11827996
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.
Wu J; Stevenson MJ; Brown JM; Grunz EA; Strawn TL; Fay WP
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):698-704. PubMed ID: 18276908
[TBL] [Abstract][Full Text] [Related]
19. The role of protease-activated receptors PAR-1 and PAR-2 in the repair of 16HBE 14o(-) epithelial cell monolayers in vitro.
Ewen D; Clarke SL; Smith JR; Berger C; Salmon G; Trevethick M; Shute JK
Clin Exp Allergy; 2010 Mar; 40(3):435-49. PubMed ID: 20210813
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
